Publication
Article
Evidence-Based Oncology
June 2021Volume27 Issue 4
Weidner et al, Appendices
Author(s):
Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology
Articles in this issue
Dollars and Sense
FDA Panel Votes to Keep 4 of 6 “Dangling Approvals,” in a Sign of Things to Come
Observations Regarding the Average Sales Price Reimbursement Methodology
Weidner et al, Appendices
Real-World Evidence Is Key to Accelerating Oncology Approvals
PATHWAYS: Oncology Care Pathways Launched by Payers: What Are the Trends?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Videos
Related Content
